These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 12678734)

  • 21. Combining aspects of the platinum anticancer drugs picoplatin and BBR3464 to synthesize a new family of sterically hindered dinuclear complexes; their synthesis, binding kinetics and cytotoxicity.
    Brown SD; Trotter KD; Sutcliffe OB; Plumb JA; Waddell B; Briggs NE; Wheate NJ
    Dalton Trans; 2012 Oct; 41(37):11330-9. PubMed ID: 22886151
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis of antitumor azolato-bridged dinuclear platinum(ii) complexes with in vivo antitumor efficacy and unique in vitro cytotoxicity profiles.
    Komeda S; Takayama H; Suzuki T; Odani A; Yamori T; Chikuma M
    Metallomics; 2013 May; 5(5):461-8. PubMed ID: 23608770
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preclinical and clinical studies on the use of platinum complexes for breast cancer treatment.
    Ott I; Gust R
    Anticancer Agents Med Chem; 2007 Jan; 7(1):95-110. PubMed ID: 17266507
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cellular accumulation and DNA interaction studies of cytotoxic trans-platinum anticancer compounds.
    Bartel C; Bytzek AK; Scaffidi-Domianello YY; Grabmann G; Jakupec MA; Hartinger CG; Galanski MS; Keppler BK
    J Biol Inorg Chem; 2012 Mar; 17(3):465-74. PubMed ID: 22227950
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Targeting drug delivery system for platinum(Ⅳ)-Based antitumor complexes.
    Zhong Y; Jia C; Zhang X; Liao X; Yang B; Cong Y; Pu S; Gao C
    Eur J Med Chem; 2020 May; 194():112229. PubMed ID: 32222677
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Platinum (II) complexes with stereochemically-defined thiepane dioxide diamine ligands as anticancer drugs.
    Cerè V; Grossi L; Munari D; Pollicino S; Martelli L; Martelli M
    Anticancer Res; 2006; 26(3A):1815-9. PubMed ID: 16827112
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Trans-platinum complexes as anticancer drugs: recent developments and future prospects.
    Radulovic S; Tesic Z; Manic S
    Curr Med Chem; 2002 Sep; 9(17):1611-8. PubMed ID: 12171556
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Platinum-based drugs: past, present and future.
    Dilruba S; Kalayda GV
    Cancer Chemother Pharmacol; 2016 Jun; 77(6):1103-24. PubMed ID: 26886018
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel bis-platinum complexes endowed with an improved pharmacological profile.
    Gatti L; Perego P; Leone R; Apostoli P; Carenini N; Corna E; Allievi C; Bastrup U; De Munari S; Di Giovine S; Nicoli P; Grugni M; Natangelo M; Pardi G; Pezzoni G; Singer JW; Zunino F
    Mol Pharm; 2010 Feb; 7(1):207-16. PubMed ID: 19919086
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Trans-platinum complexes in cancer therapy.
    Coluccia M; Natile G
    Anticancer Agents Med Chem; 2007 Jan; 7(1):111-23. PubMed ID: 17266508
    [TBL] [Abstract][Full Text] [Related]  

  • 31. DNA condensing effects and sequence selectivity of DNA binding of antitumor noncovalent polynuclear platinum complexes.
    Malina J; Farrell NP; Brabec V
    Inorg Chem; 2014 Feb; 53(3):1662-71. PubMed ID: 24428232
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Current status of and future perspectives for platinum antitumor drugs].
    Chikuma M; Sato T; Komeda S
    Yakugaku Zasshi; 2008 Mar; 128(3):307-16. PubMed ID: 18311048
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis, characterization and biological investigation of platinum(ii) complexes with asparagusic acid derivatives as ligands.
    Hildebrandt J; Trautwein R; Kritsch D; Häfner N; Görls H; Dürst M; Runnebaum IB; Weigand W
    Dalton Trans; 2019 Jan; 48(3):936-944. PubMed ID: 30565617
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A novel isomerization on interaction of antitumor-active azole-bridged dinuclear platinum(II) complexes with 9-ethylguanine. Platinum(II) atom migration from N2 to N3 on 1,2,3-triazole.
    Komeda S; Lutz M; Spek AL; Yamanaka Y; Sato T; Chikuma M; Reedijk J
    J Am Chem Soc; 2002 May; 124(17):4738-46. PubMed ID: 11971723
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Status of bi- and multi-nuclear platinum anticancer drug development.
    Zhang J; Wang L; Xing Z; Liu D; Sun J; Li X; Zhang Y
    Anticancer Agents Med Chem; 2010 May; 10(4):272-82. PubMed ID: 20184553
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The rational design of anticancer platinum complexes: the importance of the structure-activity relationship.
    Montaña AM; Batalla C
    Curr Med Chem; 2009; 16(18):2235-60. PubMed ID: 19519389
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Advances in platinum chemotherapeutics.
    Harper BW; Krause-Heuer AM; Grant MP; Manohar M; Garbutcheon-Singh KB; Aldrich-Wright JR
    Chemistry; 2010 Jun; 16(24):7064-77. PubMed ID: 20533453
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biomolecular targets for platinum antitumor drugs.
    Bose RN
    Mini Rev Med Chem; 2002 Apr; 2(2):103-11. PubMed ID: 12370072
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New metal complexes as potential therapeutics.
    Zhang CX; Lippard SJ
    Curr Opin Chem Biol; 2003 Aug; 7(4):481-9. PubMed ID: 12941423
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Platinum and Palladium Complexes as Promising Sources for Antitumor Treatments.
    Czarnomysy R; Radomska D; Szewczyk OK; Roszczenko P; Bielawski K
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34361037
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.